Navigation Links
CB1400, Patented by Canopus BioPharma, Enters Phase II Clinical Trials for the Prevention of Mucositis in Patients With Cancer of the Head and Neck
Date:6/23/2008

LOS ANGELES, June 23 /PRNewswire-FirstCall/ -- Canopus BioPharma, Inc. (OTC: CBIA), is pleased to announce that the South African Medicines Control Council has granted approval for a Phase II study in 30 cancer patients evaluating the protective effect of CB1400 on the gastrointestional tract from radiation-induced mucositis. This new trial is an important step forward in the development of CB1400 as a novel, preventative, anti-mucositis agent.

Oral and gastrointestinal (GI) mucositis is a painful, debilitating, and sometimes fatal, side-effect of radiation therapy and cancer chemotherapy. No preventative mucositis medicines are available, and few treatments are effective. With some cancer therapies, oral mucositis can develop in over 90% of patients. Consequently, it is a widespread problem with considerable economic and healthcare implications. There is a real need for an effective and well-tolerated mucositis prophylactic. The US market for a preventative mucositis agent is estimated to be over $1 billion per annum.

In work carried out on behalf of Canopus, CB1400 has already been shown to have protective and antimutagenic effects when tested in an animal model of mucositis. Complete protection of the GI tract was seen in gamma-radiated mice pre-treated with oral CB1400 (100 mg/kg/day). Even with high doses of radiation (10Gy), there was no evidence of mucositis: weight gain was observed in the CB1400 pre-treated groups; all mice treated with placebo died.

Canopus BioPharma Inc. has applied to undertake further clinical studies with leading oncologists in Australia, South Africa and the USA, investigating CB1400 as a preventative mucositis agent in head and neck cancer patients who are receiving radiation and/or chemotherapy.

About Canopus BioPharma, Inc.:

Canopus BioPharma, Inc. (OTCBB: CBIA) is dedicated to providing the safest, most cost effective and efficacious pharmaceutical products and assay methods in the areas o
'/>"/>

SOURCE Canopus BioPharma, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Impliant Restarts Pivotal Clinical Trial for Patented TOPS(TM) Spine System
2. ArtJen Announces Major Clinical Trial of Its Patented Weight Loss Product FBCx
3. Canopus BioPharma Strengthens its CB1400 Platform Technology for Mucositis and Oncology Treatments Through License Agreement With Wisconsin Alumni Research Foundation
4. Victory Pharma, Inc. Reports MGX006 Enters Into Pivotal Development Program
5. Bavarian Nordic Enters Clinical Trials with HIV Multiantigen Vaccine
6. Ovarian Cancer Vaccine Clinical Trial Begins at Cancer Treatment Centers of America
7. Top Academic Medical Centers, Research Institutions, and Partners Gather, Share Experiences and Success Stories at Velos eResearch Annual Meeting
8. World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research
9. Alseres Pharmaceuticals Enters Agreement to Amend Cethrin(R) License to Lower Milestone Payments and Royalty Rates
10. ESBATechs Lead Antibody Fragment Enters Clinical Development for Ophthalmic Indications
11. STAR Cranial Centers of Excellence Offer Cutting-Edge Treatment to Dallas Area Children
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... , March 31, 2015 ANI Pharmaceuticals, Inc. ... of Propafenone Hydrochloride 150mg, 225mg and 300mg oral tablets, ... The overall US market for Propafenone Hydrochloride 150mg, 225mg ... IMS Health. Arthur S. Przybyl , ... to announce the launch of our fourth product from ...
(Date:3/31/2015)... Texas , March 31, 2015   Unique ... operational transformation is complete and the company has initiated ... "Our goal as a company is to ... Travis Leeah . "Meeting the new regulations is ... staff. We,re embracing the future of our industry, investing ...
(Date:3/31/2015)... , Mar. 27, 2015 Research and ... the addition of the "European Laboratory Information ... System), by Type (Clinical Pathology Laboratory Information System, ... 2019" report to their offering. ... to grow at a CAGR of 7.6% from ...
Breaking Medicine Technology:ANI Pharmaceuticals Announces the Launch of Propafenone Tablets 2ANI Pharmaceuticals Announces the Launch of Propafenone Tablets 3Unique Pharmaceuticals Launches Sterile Operations under New Federal Guidance 2Unique Pharmaceuticals Launches Sterile Operations under New Federal Guidance 3European Laboratory Information System Market Report 2015: Germany holds a larger share of the laboratory information systems market 2European Laboratory Information System Market Report 2015: Germany holds a larger share of the laboratory information systems market 3
... N.J., Feb. 15, 2011 Daiichi Sankyo, Inc. (DSI), ... facility in Bethlehem Township, Pennsylvania from Amcor, a global ... leverage existing resources to more cost-effectively supplement its operations ... expected to be operational in the summer or early ...
... MAHWAH, N.J., Feb. 15, 2011 Stryker Corporation,s Orthopaedics ... most recognizable names and personalities in professional golf, has ... of the sport and current member of the PGA ... Triathlon ® Knee System in November 2009 and ...
Cached Medicine Technology:Daiichi Sankyo, Inc. Acquires First US-Based Packaging and Manufacturing Facility 2Fred Funk Becomes Spokesperson for Stryker Orthopaedics 2Fred Funk Becomes Spokesperson for Stryker Orthopaedics 3
(Date:3/31/2015)... Former 49ers linebacker Chris Borland turned more heads with ... a promising NFL career. In a March episode of ... Leitch explores the curious case of Borland and the ... making process that Borland and other football players will likely ... paycheck, and what impact, if any, he thinks this case ...
(Date:3/31/2015)... National Adaptive Sports Month will ... benefits of participating in adaptive sports activities, educate ... athletes that adapt, believe and compete each week ... fitness and inclusive athletics in our schools, provide ... sports and advocate for an increase in the ...
(Date:3/31/2015)... Purchase, NY (PRWEB) March 31, 2015 ... to announce the presentation of new clinical study ... bonded arginine silicate (ASI), titled, “Arginine Silicate Supplementation ... and Increases Markers of Vasodilation and Cardiovascular Health ... to scientists and other professionals at the acclaimed ...
(Date:3/31/2015)... The New Jersey Chapter of the ... two administrators from Windsor Healthcare Communities, a leading ... Jersey, to two key leadership roles at this ... administrator for Abingdon Care & Rehabilitation Center of ... administrator of Canterbury Care & Rehabilitation Center at ...
(Date:3/31/2015)... 31, 2015 Williams Comfort Air ... visit when their home comfort is at stake. ... the visit fit into the customer’s schedule, a ... quality repair at requested times. , To ... customers in the Indianapolis area can visit ...
Breaking Medicine News(10 mins):Health News:Will Leitch and the Curious Case of Chris Borland on SCI TV 2Health News:Will Leitch and the Curious Case of Chris Borland on SCI TV 3Health News:April is National Adaptive Sports Month 2Health News:April is National Adaptive Sports Month 3Health News:Nutrition 21, LLC Announces the Presentation of Proteomic Results of a Nitrosigine® Clinical Study at the Renowned Experimental Biology 2015 Annual Meeting 2Health News:Nutrition 21, LLC Announces the Presentation of Proteomic Results of a Nitrosigine® Clinical Study at the Renowned Experimental Biology 2015 Annual Meeting 3Health News:Nutrition 21, LLC Announces the Presentation of Proteomic Results of a Nitrosigine® Clinical Study at the Renowned Experimental Biology 2015 Annual Meeting 4Health News:Nutrition 21, LLC Announces the Presentation of Proteomic Results of a Nitrosigine® Clinical Study at the Renowned Experimental Biology 2015 Annual Meeting 5Health News:Nutrition 21, LLC Announces the Presentation of Proteomic Results of a Nitrosigine® Clinical Study at the Renowned Experimental Biology 2015 Annual Meeting 6Health News:Abingdon Care & Rehabilitation Center’s Administrator Elected President of N.J. Chapter of the American College of Health Care Administrators 2Health News:Williams Comfort Air Launches Online Scheduling Tool to Indianapolis-Area Home and Business Owners 2
... (NYSE: HB ) today announced its fiscal 2008 ... declared by Hillenbrand,s,Board of Directors on February 7, 2008, ... record at the close of business on March 17, ... is organized into two operating companies,serving the health care ...
... 6 times more likely to make mistakes , , FRIDAY, ... are about six times more likely to make medication errors ... a 123 pediatric residents at three children,s hospitals in the ... residents were depressed, and 74 percent were burned out. During ...
... CJPS Enterprises, LLC, (http://www.cjps-enterprises.com ) announced that it ... and licensing of intellectual property (IP)., The ... already,making its website available to universities, research organizations, ... "You have,to fill the shelves of the store ...
... Oversee Phase 3 Program of CGT-2168, ... Pharmaceuticals,Inc., today named a distinguished international panel ... Steering Committee charged with overseeing COGENT,the company,s ... its novel,combination antiplatelet product CGT-2168., (Logo: ...
... Mylan Inc. (NYSE: MYL ),today announced that Mylan ... judge in Florida finding that the inclusion of,Levothyroxine Sodium ... of legislative authority and that the product should be ... products available to pharmacies in Florida as soon,as motions ...
... MBF Healthcare,Acquisition Corp. (AMEX: MBH ), a ... it will host an investor,conference call on Friday, ... to,discuss the recently announced signing of a definitive ... (along with its,subsidiaries, "CHS"). Hosting the call from ...
Cached Medicine News:Health News:Depression in Young Doctors Tied to Medication Errors 2Health News:CJPS Enterprises Spins Off New Company for Intellectual Property Marketing 2Health News:Cogentus Pharmaceuticals Names Scientific Steering Committee for Global Phase 3 Clinical Program 2Health News:Cogentus Pharmaceuticals Names Scientific Steering Committee for Global Phase 3 Clinical Program 3Health News:Mylan Restores Availability of Generic Levothyroxine in Florida 2Health News:MBF Healthcare Acquisition Corp. to Host Investor Conference Call to Review Stock Purchase Agreement Signed With Critical Homecare Solutions Holdings, Inc. 2Health News:MBF Healthcare Acquisition Corp. to Host Investor Conference Call to Review Stock Purchase Agreement Signed With Critical Homecare Solutions Holdings, Inc. 3Health News:MBF Healthcare Acquisition Corp. to Host Investor Conference Call to Review Stock Purchase Agreement Signed With Critical Homecare Solutions Holdings, Inc. 4
... of some micro vascular clamps can be ... use, Stainless steel changes its elasticity, causing ... pressures above 30g/mm2 may be associated with ... titanium which does not change its elasticity ...
... daylight into the surgical suite with the ... a variety of applications - including use ... - this light source delivers instant clean ... for superb tissue definition, even in hard-to-see ...
Designed for simple operation, the Model 515C pulse oximeter is ideal for use in any clinical setting; from emergency hospital transport to continuous monitoring in Anesthesia, Intensive Care and Gen...
... The Models 512 and 513 ... processing. This advanced technology is able ... higher resolutions and speeds of 100 ... results in improved pulse oximeter performance ...
Medicine Products: